This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ou, Y. C. Articles by Yang, R. S. H. Search for Related Content PubMed PubMed Citation Articles by Ou, Y. C. Articles by Yang, R. S. H.

A Clonal Growth Model

Time-course Simulations of Liver Foci Growth following Penta- or Hexachlorobenzene Treatment in a Medium-term Bioassay¹

Quantitative and Computational Toxicology Group, Center for Environmental Toxicology and Technology, Department of Environmental Health, Colorado State University, Fort Collins, Colorado 80523 [Y. C. O., M. E. A., L. S. C., R. S. H. Y.]; Chemical Industrial Institute of Toxicology Centers for Health Research, Research Triangle Park, North Carolina 27709 [R. B. C.]; and McArdle Laboratory for Cancer Research, Madison, Wisconsin 53706 [R. S. T., Y. X., H. C. P.]

A combination of experimental and simulation approaches were used to analyze the clonal growth of preneoplastic, enzyme-altered foci during liver carcinogenesis in an initiation-promotion regimen. Male Fisher 344 rats, 8 weeks of age, were initiated with a single dose (200 mg/kg, i.p.) of diethylnitrosamine (DEN). Beginning 2 weeks later, animals were exposed to daily gavage consisting of 0.1 mmol/kg pentachlorobenzene (PECB) or hexachlorobenzene (HCB) in corn oil vehicle for 6 weeks. Partial hepatectomy was performed 3 weeks after initiation. Experimental data including liver weight, hepatocyte density (number of hepatocytes/unit volume), 5-bromo-2'-deoxyuridine-labeling index for analysis of cell division rate, and number and volume of glutathione-S-transferase -positive foci were collected 23, 26, 28, 47, or 56 days after initiation. Model parameters describing liver growth were obtained directly from the experimental data. The probability of mutation/division of normal cells and the growth rate of initiated cells were inferred by a comparison of model outcomes with the observed time courses of foci development. To describe the time-dependent increases in foci volume and the concomitant reduction of foci number observed in all treatment groups, the calibrated model for the DEN controls incorporated the hypothesis of two initiated cell populations (referred to as A and B cells) within the framework of the two-stage model. The B cells are initiated cells that have a selective growth advantage under conditions that inhibit the growth of A cells and normal hepatocytes. The parameter values defined in the DEN controls were used to evaluate experiments involving the administration of PECB or HCB. Both PECB and HCB caused a significant increase in foci volume compared with the DEN controls. HCB treatments resulted in increased proliferation of normal hepatocytes, which was not observed for PECB under the same treatment regimen. The best description of the data resulted from the model incorporating the hypothesis that PECB and HCB promoted the growth of foci via increased net growth rates of B cells. We present here a biologically based clonal growth simulation platform to describe the growth of preneoplastic foci under experimental manipulations of initiation-promotion studies. This simulation work is an example of quantitative approaches that could be useful for the analysis of other initiation-promotion studies.

This article has been cited by other articles:

				F. Chiappini, L. Alvarez, V. Lux-Lantos, A. S. Randi, and D. L. Kleiman de Pisarev Hexachlorobenzene Triggers Apoptosis in Rat Thyroid Follicular Cells Toxicol. Sci., April 1, 2009; 108(2): 301 - 310. [Abstract] [Full Text] [PDF]

				M. Lohitnavy, Y. Lu, O. Lohitnavy, L. S. Chubb, S. Hirono, and R. S. H. Yang A Possible Role of Multidrug Resistance-Associated Protein 2 (Mrp2) in Hepatic Excretion of PCB126, an Environmental Contaminant: PBPK/PD Modeling Toxicol. Sci., July 1, 2008; 104(1): 27 - 39. [Abstract] [Full Text] [PDF]

				Y. Lu, M. Lohitnavy, M. B. Reddy, O. Lohitnavy, A. Ashley, and R. S. H. Yang An Updated Physiologically Based Pharmacokinetic Model for Hexachlorobenzene: Incorporation of Pathophysiological States following Partial Hepatectomy and Hexachlorobenzene Treatment Toxicol. Sci., May 1, 2006; 91(1): 29 - 41. [Abstract] [Full Text] [PDF]

				Y. C. Ou, R. B. Conolly, R. S. Thomas, D. L. Gustafson, M. E. Long, I. D. Dobrev, L. S. Chubb, Y. Xu, S. A. Lapidot, M. E. Andersen, et al. Stochastic Simulation of Hepatic Preneoplastic Foci Development for Four Chlorobenzene Congeners in a Medium-Term Bioassay Toxicol. Sci., June 1, 2003; 73(2): 301 - 314. [Abstract] [Full Text] [PDF]

				P. D. Hockings, T. Roberts, S. P. Campbell, D. G. Reid, R. W. Greenhill, S. R. Polley, P. Nelson, T. A. Bertram, and K. Kramer Longitudinal Magnetic Resonance Imaging Quantitation of Rat Liver Regeneration After Partial Hepatectomy Toxicol Pathol, August 1, 2002; 30(5): 606 - 610. [Abstract] [PDF]